Aquestive Therapeutics (AQST)
(Delayed Data from NSDQ)
$2.42 USD
-0.03 (-1.22%)
Updated Jul 2, 2024 04:00 PM ET
After-Market: $2.42 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/05/2024
Time: -- |
6/2024 | $-0.11 | -22.81% |
Earnings Summary
For their last quarter, Aquestive Therapeutics (AQST) reported earnings of -$0.17 per share, missing the Zacks Consensus Estimate of -$0.09 per share. This reflects a negative earnings surprise of 88.89%. Look out for AQST's next earnings release expected on August 05, 2024. For the next earning release, we expect the company to report earnings of -$0.11 per share, reflecting a year-over-year decrease of 10%.
Earnings History
Price & Consensus
Zacks News for AQST
Compared to Estimates, Aquestive Therapeutics (AQST) Q1 Earnings: A Look at Key Metrics
AQST: What are Zacks experts saying now?
Zacks Private Portfolio Services